About ::The Signio Difference
Signio is a specialty pharmacy supporting patients with complex, rare and orphan diseases. 

About Us

Signio is a specialty pharmacy supporting patients with complex, rare and orphan diseases. The company enables patients to successfully live with complex diseases by serving as an active partner throughout their entire journey with integrity, compassion and excellence. Signio understands the challenges patients face while navigating through the healthcare system. The company takes a comprehensive approach to “connect the dots” between patients, prescribing physicians, biopharmaceutical manufacturers, and payors. This ensures that patients receive the treatment they need in the timeline that’s most helpful with minimal financial impact.

Headquartered in New Jersey, Signio is a subsidiary of the Polaris Pharmacy Services family of companies. Signio team members work diligently to ensure the best clinical outcomes by building customized programs around our patients and their individual disease states.

Our Core Values

Our mission is to promote optimal outcomes for persons enduring rare, orphan and complex clinical conditions. Six core values drive our business and team while delivering value for patients each day.

  1. Integrity is maintained by putting our patients first, being honest, transparent and ethical about our intention.
  2. Accountability is taking ownership and responsibility for our actions.
  3. Excellence through constant evaluation and innovation, defines our tireless pursuit to achieve optimal outcomes.
  4. Communication is comprehensive and compassionate, and drives patient treatment success.
  5. Passion parallels our relentless ambition to provide optimal care and individualized solutions.
  6. Diversity within the organization keeps us interconnected with patients on a personal level which propels out success.

Signature Services

Complex Coordination of Benefits
Compliance and Persistency
Flexible Case Management

About Rare and Orphan Diseases

The Orphan Drug Act defines a rare disease as a disease or condition that impacts less than 200,000 people in the United States. Rare diseases are characterized by a wide diversity of symptoms that vary not from one disease to another as well as from patient-to-patient suffering from the same conditions. This diversity adds complexity that Signio is well equipped to help patient and our partners effectively manage. Learn more about Signio’s focus areas and the related therapies on which we focus.